BenzaClin dermatology data

In an evaluator-blind trial in 132 patients, BenzaClin (Group 1) significantly reduced inflammatory lesions at week 2 compared with 0.025% tretinoin plus 1% clindamycin (Group 2) and BenzaClin plus 0....